Biotech
Human history has been all but defined by death and disease, plague and pandemic. Advancements in 20th century medicine changed all of that. Now advancements in 21st century medicine promise to go even further. Could we bring about an end to disease? Reverse aging? Give hearing to the deaf and sight to the blind? The answer may be yes. And soon.
More
When will we have a COVID-19 vaccine?
Several developers have reported incredible coronavirus vaccine progress, so when will we have a COVID-19 vaccine ready for distribution?
Reverse engineering a $15k medical device for 50x less
Many hospitals in developing countries can’t access the overpriced, high-tech equipment that’s standard in the U.S. Reverse innovation could finally change that.
Oxford says its COVID-19 vaccine is up to 90% effective
The University of Oxford’s COVID-19 vaccine was up to 90% effective in a phase 3 trial and could be easier to distribute than other coronavirus vaccines.
How long will coronavirus immunity last?
Coronavirus immunity might last for years, according to a new study that measured the levels of virus-fighting immune cells in COVID-19 survivors.
New skin cancer vaccine is twice as powerful
By adding two “boosters” to an in-development skin cancer vaccine, scientists may have improved its ability to prevent melanoma recurrence.
Do apologies even matter?
Science is finally proving that the act of apologizing can save and strengthen a relationship that’s been damaged by conflict.
Bacteria could make space mining 400% more efficient
Using a bioreactor packed with bacteria could make space mining more efficient by speeding up the extraction of elements from rock.
New vanishing wound dressing heals skin with minimal scarring
A new kind of hydrogel dressing improves wound healing and minimizes scarring by kicking the adaptive immune system into gear.
FDA authorizes first at-home COVID-19 test
The FDA has authorized an at-home COVID-19 test that delivers results in 30 minutes, but you can’t get it without a prescription.
Bacteria’s self-destruct mechanism may unlock next-level genome editing
A mystery for 30 years, retrons are showing potential as genome-editing tools. Now, we know what they actually do.
The most detailed map of the human heart
A new map of the human heart details the function and location of 500,000 cells, providing a valuable tool for researchers studying cardiovascular disease.
Trial suggests Moderna’s coronavirus vaccine is 95% effective
Another win for mRNA vaccines: Moderna’s coronavirus vaccine appears to be 94.5% effective at preventing COVID-19, according to initial trial data.
New “universal” diagnostic test can ID any infection
UC San Francisco scientists have developed a new diagnostic test that uses DNA sequencing to quickly identify any pathogens in any type of patient sample.
A flu vaccine grown in tobacco plants just aced its clinical trials
Plant-based vaccines can be made cheaply and at scale. A tobacco plant-based vaccine for influenza has now been the first to complete clinical trials.
Finally! A smart toilet offers fecal testing for the masses
Fecal testing can reveal a surprising amount of medical data. Israeli startup OutSense wants to do so from your home.
Can a new polio vaccine help finish the virus off once and for all?
Thanks to polio vaccines and public health campaigns, polio is on the run — although COVID has it fighting back. Can a new vaccine help turn the tide again?
“Virus burritos” could be the key to vaccine preservation
Vaccine preservation is crucial to world health; the WHO estimates we waste 50% of vaccines a year. Vaccine burritos may provide some help.
Gene therapy shows promise as a glaucoma treatment
A new gene therapy was able to repair a damaged optic nerve in mice, suggesting it might be useful for treating glaucoma in people.
Is free will an illusion?
Philosophers have been making the claim that free will is an illusion for hundreds of years. What does modern neuroscience have to say about it?
Pfizer COVID-19 vaccine appears 95% effective (updated)
The Pfizer COVID-19 vaccine appears to be 95% effective at preventing coronavirus infections, according to an early analysis of a Phase 3 trial.
Subscribe to the newsletter